Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404635 · ClinicalTrials.gov registry record
Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
A clinical trial of Venous Thromboembolism, sponsored by Indiana University.
- Completed
- Registry status
- 1,300
- Enrollment target
- 2
- Study locations
NCT03404635 is a study of Venous Thromboembolism that has completed, run by Indiana University. The registered enrollment target is 1,300 participants, below the 6,268-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03404635, a study of Venous Thromboembolism, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 1,300 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective, multicenter observational study, of the effectiveness of a standard of care protocol implemented to enhance home treatment of VTE. Study population will be selected as part of usual care as eligible for home treatment. Study personnel will travel to participating institutions to qualify the sites, deliver a Powerpoint® lecture to introduce the protocol, meet and train site principal investigators, emergency physicians and research personnel on the implementation of the protocol as part of usual clinical care, and data collection methods for a quality assurance registry with plans to use the data collected in this registry in future publications. Follow-up will be 30 days using medical records and/or telephone interview to assess for primary outcomes of bleeding or VTE recurrence.
Conditions Studied
Interventions
- DRUG Apixaban
- DRUG Rivaroxaban
Study Locations (2)
Indiana
- Eskenazi Health System - Indianapolis
- Indiana University Health Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2020-05-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03404635
The ClinicalTrials.gov registry entry for NCT03404635 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,268-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (79% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Venous Thromboembolism appearing as the primary indexed condition, and to 2 interventions - of which Apixaban is the first listed.
NCT03404635 reports 2 study locations spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT03404635 about?
NCT03404635 is a clinical study titled "Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism". Prospective, multicenter observational study, of the effectiveness of a standard of care protocol implemented to enhance home treatment of VTE. Study population will be selected as part of usual care as eligible for home treatment. Study personnel will travel to participating institutions to qualify...
What is the current status of trial NCT03404635?
This trial is currently completed. The enrollment target is 1,300 participants. The study started on 2017-08-04. Estimated completion is 2020-05-08.
What conditions does trial NCT03404635 study?
This clinical trial studies the following conditions: Venous Thromboembolism.
What interventions are being tested in trial NCT03404635?
The interventions under investigation include: Apixaban (DRUG), Rivaroxaban (DRUG).
Who is sponsoring clinical trial NCT03404635?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03404635 being conducted?
This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thromboembolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Venous Thromboembolism Prevention in Outpatients With Glioma
RECRUITING · Phase 2
-
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
RECRUITING
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
RECRUITING
-
Evaluation of the SCALED (SCaling AcceptabLE cDs)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.